Frederick W Driscoll insider trades

Open-market stock purchases and sales by Frederick W Driscoll, Director at Cellectar Biosciences, Inc, from SEC Form 4 filings since Mar 15, 2010.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +103%.

Recent trades

DateStockTradeValue
Jul 7, 2026CLRB Cellectar Biosciences, IncBought (not open market)—
Nov 14, 2025LITS Lite Strategy, IncBought (not open market)$111K

Companies traded

  • CLRB Cellectar Biosciences, Inc: 1 buy, last Jul 7, 2026
  • LITS Lite Strategy, Inc: other filings, last Nov 14, 2025
  • MEIP MEI Pharma, Inc: 1 buy, 1 sale, last Jul 15, 2025
  • CUE Cue Biopharma, Inc: other filings, last Jan 2, 2025
  • RCOR Renovacor, Inc: other filings, last Mar 28, 2022
  • FLXN Flexion Therapeutics Inc: 2 buys, 3 sales, last Nov 19, 2021
  • NK NantKwest, Inc: 3 sales, last Aug 11, 2020
  • OXGN Oxigene Inc: other filings, last Jun 1, 2016
  • NVAX Novavax Inc: 1 buy, last Mar 2, 2013

Get free alerts when Frederick W Driscoll files a new trade →